| Property | Value |
|---|
|
?:abstract
|
-
Highlights Fasting blood glucose < 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19.
-
Highlights Fasting blood glucose < 10 mmol/L was proposed as a target of glycemic control during the first week of hospitalization in patients with preexisting diabetes. Poor HbA1c levels prior to coronavirus disease 2019 (COVID-19) might not be associated with severity among patients with preexisting diabetes. Mean blood glucose seemed not to be associated with poor prognosis of COVID-19. Dynamics of fasting blood glucose, mean 2-hour postprandial blood glucose of coronavirus disease 2019 (COVID-19) patients with preexisting diabetes. This figure depicts the average values of (A) fasting blood glucose, (B) daily mean 2-hour postprandial blood glucose of COVID-19 patients with preexisting diabetes. Red lines represent the patients with preexisting diabetes who progressed to severe illness during admission (n=23), and blue lines represent those with preexisting diabetes who stayed nonsevere (n=26).
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
J._diabetes_(Online)
-
J_Diabetes
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: A multicenter observational study
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}